112 related articles for article (PubMed ID: 1739178)
1. Improvement in survival of mice with proximal small bowel obstruction treated with octreotide.
Gittes GK; Nelson MT; Debas HT; Mulvihill SJ
Am J Surg; 1992 Feb; 163(2):231-3. PubMed ID: 1739178
[TBL] [Abstract][Full Text] [Related]
2. [Effects of octreotide on small bowel obstructions in rats].
Cho JH; Kang HG; Kim SH; Lee HS; Lee KR; Kang HY
Korean J Gastroenterol; 2003 Oct; 42(4):283-8. PubMed ID: 14634347
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.
Currow DC; Quinn S; Agar M; Fazekas B; Hardy J; McCaffrey N; Eckermann S; Abernethy AP; Clark K
J Pain Symptom Manage; 2015 May; 49(5):814-21. PubMed ID: 25462210
[TBL] [Abstract][Full Text] [Related]
4. Surgical manifestations of ascariasis in childhood.
Rahman H; Pandey S; Mishra PC; Sharan R; Srivastava AK; Agarwal VK
J Indian Med Assoc; 1992 Feb; 90(2):37-9. PubMed ID: 1588117
[TBL] [Abstract][Full Text] [Related]
5. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
Hisanaga T; Shinjo T; Morita T; Nakajima N; Ikenaga M; Tanimizu M; Kizawa Y; Maeno T; Shima Y; Hyodo I
Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute postoperative ileus with octreotide.
Cullen JJ; Eagon JC; Dozois EJ; Kelly KA
Am J Surg; 1993 Jan; 165(1):113-9; discussion 119-20. PubMed ID: 8418686
[TBL] [Abstract][Full Text] [Related]
7. Palliation of malignant intestinal obstruction using octreotide.
Khoo D; Hall E; Motson R; Riley J; Denman K; Waxman J
Eur J Cancer; 1994; 30A(1):28-30. PubMed ID: 7511400
[TBL] [Abstract][Full Text] [Related]
8. Octreotide may prevent definitive intestinal obstruction.
Mercadante S; Kargar J; Nicolosi G
J Pain Symptom Manage; 1997 Jun; 13(6):352-5. PubMed ID: 9204656
[TBL] [Abstract][Full Text] [Related]
9. Medical Therapy of Malignant Bowel Obstruction With Octreotide, Dexamethasone, and Metoclopramide.
Berger J; Lester P; Rodrigues L
Am J Hosp Palliat Care; 2016 May; 33(4):407-10. PubMed ID: 25646530
[TBL] [Abstract][Full Text] [Related]
10. Octreotide for malignant bowel obstruction: twenty years after.
Mercadante S; Porzio G
Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783
[TBL] [Abstract][Full Text] [Related]
11. Octreotide in malignant intestinal obstruction.
Pandha HS; Waxman J
Anticancer Drugs; 1996 Jan; 7 Suppl 1():5-10. PubMed ID: 8822079
[TBL] [Abstract][Full Text] [Related]
12. The effect of somatostatin on experimental intestinal obstruction.
Mulvihill SJ; Pappas TN; Fonkalsrud EW; Debas HT
Ann Surg; 1988 Feb; 207(2):169-73. PubMed ID: 2893593
[TBL] [Abstract][Full Text] [Related]
13. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.
Mercadante S; Ripamonti C; Casuccio A; Zecca E; Groff L
Support Care Cancer; 2000 May; 8(3):188-91. PubMed ID: 10789958
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gastrointestinal fistulas with Sandostatin.
Sitges-Serra A; Guirao X; Pereira JA; Nubiola P
Digestion; 1993; 54 Suppl 1():38-40. PubMed ID: 8359567
[TBL] [Abstract][Full Text] [Related]
15. The use of octreotide in bowel obstruction.
Mercadante S
Palliat Med; 1993; 7(1):78. PubMed ID: 8287204
[No Abstract] [Full Text] [Related]
16. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
[TBL] [Abstract][Full Text] [Related]
17. Clinician-reported changes in octreotide prescribing for malignant bowel obstruction as a result of an adequately powered phase III study: A transnational, online survey.
Campbell R; McCaffrey N; Brown L; Agar MR; Clark K; Currow DC
Palliat Med; 2018 Sep; 32(8):1363-1368. PubMed ID: 29856291
[TBL] [Abstract][Full Text] [Related]
18. Effects of octreotide and a-tocopherol on bacterial translocation in experimental intestinal obstruction: a microbiological, light and electronmicroscopical study.
Reis E; Kama NA; Coskun T; Korkusuz P; Ors U; Aksoy M; Kulaçoglu S
Hepatogastroenterology; 1997; 44(15):656-63. PubMed ID: 9222666
[TBL] [Abstract][Full Text] [Related]
19. Radiological imaging change in a malignant bowel obstruction patient treated with octreotide.
Shinjo T; Kagami R
Support Care Cancer; 2009 Jun; 17(6):753-5. PubMed ID: 19277723
[TBL] [Abstract][Full Text] [Related]
20. Octreotide for malignant bowel obstruction: commentary on Currow et al.
Mercadante S
J Pain Symptom Manage; 2015 May; 49(5):813. PubMed ID: 25863013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
